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The STEZ gene of the  yeast  Saccharomyces  cerevis- 
iae encodes a 431-residue  polypeptide that  has been 
shown by chemical  cross-linking  and  genetic  studies  to 
be a component of the  receptor  for  the peptide  mating 
pheromone,  a-factor.  To  demonstrate  directly that  the 
ligand  binding  site of the  a-factor  receptor is comprised 
solely of the STEZ gene  product,  the STEZ protein  was 
expressed  in  Xenopus oocytes. Oocytes microinjected 
with  synthetic STEZ mRNA displayed  specific surface 
binding  for  36S-labeled  a-factor  (up  to 40 sites/pm2/ng 
RNA). Oocytes injected with either STEZ antisense 
RNA or heterologous receptor mRNA (nicotinic ace- 
tylcholine receptor a, B, y, and 8 subunit mRNAs) 
showed no binding  activity  (indistinguishable  from  un- 
injected  control oocytes). The  apparent KD (7 nM) of 
the  a-factor  binding  sites expressed  on the oocyte sur- 
face,  determined by competition  binding  studies, 
agreed  with  the values  reported  for  intact  yeast  cells 
and  yeast  plasma  membrane  fractions.  These  findings 
demonstrate that  the STE2 gene  product is the only 
yeast polypeptide required  for biogenesis of a func- 
tional  a-factor  receptor. Electrophysiological  measure- 
ments indicated that the membrane conductance of 
oocytes injected  with STE2 mRNA, or with  both STE2 
and GPAl  (encoding a yeast G protein a-subunit) 
mRNAs, did not change  and  was not affected by pher- 
omone binding.  Thus, the  a-factor  receptor,  like mam- 
malian G protein-coupled  receptors, apparently  lacks 
activity as an intrinsic or ligand-gated ion channel. 
This  report is the  first  instance  in which  a  membrane- 
bound  receptor  from  a  unicellular  eukaryote  has been 
expressed  in a vertebrate cell. 
In  the yeast Saccharomyces  cereuisiae, MATa and MATa 
haploid cells each secrete an oligopeptide mating pheromone 
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(a-factor and a-factor, respectively) that acts specifically 
upon the opposite haploid cell type (1, 2). Haploid cells 
exposed to mating pheromone display a  series of physiological 
responses that are preparatory for conjugation, including 
rapid changes in gene expression, arrest of cell growth in the 
G1 phase of the cell  cycle, and alterations in cell surface and 
nuclear morphology (3, 4). It has also been reported that 
pheromone response in MATa cells is accompanied by both 
rapid (5)  and sustained (6) increases in Ca2+ uptake, although 
it is uncertain whether these Ca2+ fluxes are an obligatory 
part of the cellular response to mating pheromone. 
The mating response pathway in  yeast is mediated through 
a G protein-linked signal transduction system. Haploid MATa 
cells possess on their surface saturable binding sites for a- 
factor, which have been shown genetically and biochemically 
to be encoded, at least in part, by the STE2 gene. Cells 
carrying temperature-sensitive ste2 mutations display ther- 
mosensitive a-factor binding activity in uitro (7,8). Chemical 
cross-linking to radiolabeled a-factor (9), and  the changes in 
ligand binding specificity observed when a STE2 homolog 
from another yeast species (SGccharomyces  kluyueri) was ex- 
pressed in S. cereuisiae (lo), have demonstrated that  the STE2 
product  contributes to  the ligand recognition activity of the 
a-factor receptor. Hydropathy analysis indicates that the 
predicted STEB gene product (11, 12) contains seven hydro- 
phobic segments followed by a hydrophilic C-terminal region, 
a structural motif common to mammalian G protein-linked 
receptors. Indeed, immunological and biochemical analyses 
have confirmed that the STEB gene product is a plasma 
membrane-associated glycoprotein and that its C-terminal 
hydrophilic domain is disposed on the cytosolic side of the 
membrane (9, 13, 14). 
Genetic evidence indicates that pheromonal signals are 
transduced, directly or indirectly, from the receptor to a 
guanine nucleotide-binding protein (G protein).  Inactivation 
of the GPAl gene, which encodes a protein homologous to 
mammalian G, subunits,  results  in  constitutive  induction of 
the pheromone response pathway (15-18). Null mutations  in 
the STE4 and STE18 genes (which encode GP and G, subunit 
homologs, respectively) block response to mating pheromone 
(19). 
In  this report, the Xenopus oocyte expression system and 
direct a-factor binding assays were employed to determine if 
the yeast STE2 gene product was sufficient, as well as nec- 
essary, to form a functional pheromone receptor. Electro- 
physiological measurements were used to explore the potential 
consequences of expressing functional a-factor receptors in 
amphibian oocytes. The results obtained have significant 
implications for understanding the subunit composition of 
the  a-factor receptor, the potential biochemical function of 
the receptor in  transmembrane signaling, and  the evolution- 
ary conservation of G protein-coupled signal transduction 
systems. 
EXPERIMENTAL  PROCEDURES 
Enzymes and Chemicals-Materials were obtained from the follow- 
ing sources: T7 RNA polymerase from the United States Biochemical 
Corp.; the  RNase inhibitor RNasin from Promega Biotec; restriction 
endonucleases from New England Biolabs, Boehringer Mannheim, 
and Bethesda  Research  Laboratories; mRNA cap analog, GpppGoH 
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carrier-free [3sSS]H2S04, for preparation of “S-labeled a-factor  from 
DU  Pont-New  England Nuclear; and  synthetic  a-factor  from  Penin- 
sula Laboratories. 
Plasmids-Plasmid pT7STE2,  in which expression of STEP 
mRNA  can be driven by a phage T 7  promoter,  has been described 
previously (9). To place the STE2 coding region in the antisense 
orientation  under  transcriptional  control of a T7 promoter,  the 2.2- 
kilobase pair EamHI fragment of pT7STE2 was inserted into the 
BamHI  site of pGEMl  (Promega Biotec). The  structure of the  re- 
sultant  plasmid,  pGEM1-STE2, was  verified by appropriate  restric- 
tion endonuclease  mapping. The  GPAl gene was obtained by screen- 
ing a  yeast genomic library (20) with  a synthetic 25-base oligonucle- 
otide  derived  from the published  gene  sequence (16,21). T o  place the 
GPAI coding region under transcriptional control of a phage SP6 
promoter, a 1.9-kilobase pair EcoRI fragment  containing  the  entire 
GPAl gene was inserted into the EcoRI site of pGEM2 (Promega 
Biotec).  Appropriate restriction endonuclease mapping confirmed the 
structure of the  resultant  plasmid,  pGEM2-GPAI. 
Template Preparation  and  in Vitro Transcription-The  procedure 
of White  et al. (22) was used with  some  modifications (23) for in vitro 
transcription of mRNA  or  antisense RNA. T7 or SP6 RNA polym- 
erases were employed a t  a final  concentration of 600 units/ml. To 
monitor RNA synthesis, [a-32P]CTP (Du Pont-New England Nu- 
clear) was included in transcription  reactions a t  a specific activity of 
40 mCi/mmol, and a portion of each reaction mixture was treated 
with glyoxal, subjected to gel electrophoresis (24),  and  examined by 
autoradiography. STEP mRNA was synthesized by transcription of 
pT7 STEP that  had been  digested  with HindIII. STEP antisense  RNA 
was  produced by transcription of pGEM1-STE2 cleaved  with XbaI. 
GPAl mRNA was made by transcription of pGEM2-GPA1 also 
cleaved with XbaI. In  the  resultant  mRNA,  the GPAl initiation codon 
is preceded by 210 nucleotides that lack other AUG codons. Trans- 
lation of this  mRNA  in a rabbit reticulocyte  lysate (Promega Biotec) 
yielded a  49-kDa protein,  in  agreement with the  predicted size (16, 
21) of the GPAl gene product.’ The  mRNA corresponding to  the a, 
prepared from plasmids pMARA, pMARB,  pMARG,  and  pMARD 
@,y ,  and 6 subunits of Torpedo nicotinic acetylcholine  receptor were 
(25), as described before (23). 
Preparation of Oocytes, RNA Injection, and Electrophysiology- 
Mature female Xenopus frogs were obtained  from commercial sup- 
pliers (Xenopus  I, Inc.). Preparation of oocytes and  RNA injections 
were performed as described  previously (23). Oocytes were typically 
injected with 50 nl of a 1 mg/ml solution of RNA  synthesized  in vitro 
from the desired plasmids. Voltage clamp experiments were per- 
formed on oocytes to  monitor  any  transmembrane ionic currents  in 
response to  a-factor  stimulation, using  a  two-microelectrode  voltage 
clamp  as described  previously (23) 
Preparation of Purified 3sSS-Labeled a-Factor-Isolation of 35S- 
labeled a-factor from the culture fluid of yeast cells labeled with 
carrier-free [35S]H,S04 has been  described in detail previously (9). 
a-Factor  Binding Assay-Binding assays employing  oocytes were 
conducted at  room temperature (20 “C) in 24-well dishes (Falcon 
3047) containing  Barth’s medium (pH 7.4) supplemented with anti- 
biotics (either 0.5 mg/ml gentamycin  sulfate,  or 100 units/ml  potas- 
sium penicillin G and 0.1 mg/ml streptomycin sulfate) and with 1 
mg/ml bovine serum  albumin  (“oocyte  solution”). Oocytes were pre- 
washed for 5 min  and  then  incubated for 60 min  with orbital  shaking 
at 150 rpm in oocyte solution containing various concentrations of 
3sS-labeled a-factor. Oocytes then were washed four times (1 min/ 
wash) with  oocyte  solution  lacking a-factor. Individual  oocytes were 
transferred  to  scintillation vials and submerged in 3 ml of scintillation 
fluid (Safety-Solve, Research Products International Corporation). 
Radioactivity was quantified at  room temperature using  a scintillation 
spectrometer  (Packard) with the energy windows set for 14C (”SI and 
‘H. Because binding of 35S-labeled a-factor to the oocyte surface 
resulted in  little  quenching of radioactivity (<5%),  correction of the 
raw data was not performed. To measure total surface binding  sites, 
‘35SS-labeled a-factor was present  in  binding  reactions a t  a concentra- 
tion of  5-10  nM. In  competition  experiments, %-labeled a-factor was 
present at  0.5 nM, and  the labeled a-factor  and various concentrations 
of unlabeled synthetic  a-factor were added simultaneously. 
Immunological Detection of Proteins Expressed in Oocytes-To 
detect production of the  yeast G, subunit  in oocytes injected with 
GPAl mRNA, three batches of 5 oocytes each (uninjected, saline- 
injected, or GPAl mRNA-injected) were homogenized in 100 p1 of 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample 
’ K. J. Blumer,  unpublished data. 
buffer  (9),  and  heated at 95  “C for 5 min. The  extracts were clarified 
by centrifugation (10,000 X g, 1 min), and fractionated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (9).  Proteins were 
transferred electrophoretically to nitrocellulose sheets  and probed as 
described (37) using  affinity-purified GPAl -specific antibodies? 
RESULTS AND DISCUSSION 
To  test whether the ligand binding capacity of the yeast a- 
factor receptor is contributed solely by the STE2 gene prod- 
uct, and  to explore potential modes of action of this receptor, 
STE2 mRNA prepared in vitro was microinjected into Xeno- 
pus oocytes. At various intervals after injection (1-7 days), 
oocytes were assayed for their ability to bind radiolabeled a- 
factor (see “Experimental Procedures”) at concentrations 
near the KD reported for the a-factor receptor on yeast cells 
(7-9). One to two days after injection, oocytes showed surface 
binding sites for a-factor at  levels of 1.5-10 fmol/oocyte (data 
not shown). When expressed as  the number of binding sites 
per unit area of membrane surface, up to 40 sites/pm2/ng 
RNA  were obtained; this level is approximately 5-fold greater 
than  the density of a-factor receptors  present  on the surface 
of wild-type MATa cells (7-9). Expression of a-factor binding 
activity was not a transient phenomenon because >70% of 
the initial binding activity remained even 7 days after RNA 
injection (data  not shown). The number of a-factor binding 
sites per oocyte did vary, however, among oocytes obtained 
from different animals (0.5-10 fmol/oocyte) and depended on 
the particular  preparation of STE2 mRNA injected; similar 
variations have been observed with oocyte expression of other 
membrane-bound proteins (23, 26). Nevertheless, when a 
single mRNA preparation was used, the expression level of a- 
factor binding sites was reasonably consistent (coefficient of 
variation <0.35) among oocytes obtained from a single frog. 
Because of these observations, for the individual experiments 
described below, oocytes were obtained from a single animal 
and were analyzed 2 days after injection. 
Two approaches were used to determine if the a-factor 
binding activity expressed in oocytes exhibited the character- 
istics of the  authentic yeast pheromone receptor. First, oo- 
cytes injected with no RNA, STE2 antisense RNA, or Torpedo 
nicotinic acetylcholine receptor a ,  8, y, and 6 subunit mRNAs 
were assayed for pheromone binding activity. All three  types 
of control oocytes displayed at  least 10-fold lower binding 
activity than oocytes injected with STE2 mRNA (Fig. 1). 
Thus,  a-factor binding activity was elicited only upon injec- 
tion of STE2 mRNA and was not due to nonspecific binding 
resulting from the presence of another membrane-bound 
receptor or resulting from perturbation of the oocyte surface 
due to  the injection process itself. Second, competition bind- 
ing experiments employing increasing concentrations of un- 
labeled synthetic  a-factor were used to estimate the equilib- 
rium dissociation constant (KD) of the  a-factor binding sites 
expressed on the oocyte surface. When the  data were corrected 
for the effects of isotope dilution and expressed according to 
the method of Klotz (27) (Fig. 2), a value of 7 nM was 
calculated for the KD. This value is in good agreement with 
that determined for the  authentic a-factor receptor expressed 
on the surface of intact yeast cells and in isolated yeast 
membrane fractions (8,9). 
The high level and stable expression of a-factor binding 
sites exhibiting a ligand affinity essentially identical to  that 
of the  authentic yeast pheromone receptor demonstrates that 
STE2 protein is the only yeast gene product required for  the 
synthesis, membrane targeting, and insertion of a  functional 
K. J. Blumer  and J. Thorner,  submitted for  publication to Proc. 
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FIG. 1. a-Factor  binding  to Xenopus oocytes  microinjected 
with  different RNA species. Oocytes ( n  = 6-8) were microinjected 
with 50 nl of desired RNA solutions  at 1 mg/ml, or left uninjected ( n  
= 10-18) as controls. After incubation at 20 "C for 2 days, injected 
and control oocytes were subjected to analysis of surface binding for 
"S-labeled a-factor (see "Experimental Procedures"). The results 
were normalized to the mean of surface binding of STE2 mRNA- 
injected oocytes and were expressed as percentages. The error bar 
indicates S.E. Each panel represents the data obtained using  oocytes 
from a single frog. A, comparison of the binding activity of  oocytes 
injected with STE2 mRNA or antisense RNA. I?, comparison of the 
binding activity of oocytes injected with STE2 mRNA and oocytes 
injected with a mixture of mRNAs encoding the a, B,?, and 6 subunits 
of the nicotinic acetylcholine receptor (AChR) (23, 25). 
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FIG. 2. Determination of the dissociation constant  for "S- 
labeled a-factor  binding by  competition with  unlabeled  syn- 
thetic  a-factor. Oocytes ( n  = 9-11 for each data point) were injected 
with 50 nl of 1 mg/ml STE2 mRNA, incubated at 20 "C for  1-2 days, 
and their capacity to bind "S-labeled a-factor at a concentration of 
0.5 nM in the presence of various concentrations of unlabeled a-factor 
was measured. Data are corrected for the effects of isotope dilution 
and then plotted according to the method of Klotz (27). The smooth 
line represents a computer-derived best fit of the data, assuming that 
displacement of labeled ligand is first order with respect to the 
concentration of unlabeled synthetic a-factor. 
a-factor binding site. The simplest interpretation of these 
results  is  that  the  yeast  a-factor  receptor  is composed solely 
of the STE2 gene product,  consistent  with  the view that G 
protein-coupled  receptors, in general, consist of single  poly- 
peptide  chains  that  are responsible  for  ligand  recognition  (28). 
I t  is also interesting to  note  that  membrane localization of 
the  yeast  receptor occurred  efficiently in a  heterologous host 
cell. 
Although pheromonal  signaling  in  yeast is transduced  via 
G protein-coupled receptors  and involves a  common pathway 
in  both MATa and MATa cells  (29,  30), the  identity of the 
intracellular second messenger(s) has been elusive. Oocytes 
have been used to detect receptor-mediated activation of 
various  second  messenger  systems.  Ligand binding to mem- 
brane  receptors  that  have  an  intrinsic  ion  channel  activity 
can be readily detected by changes  in ionic conductance (23, 
31). In  addition, ligand binding  to  surface  receptors coupled 
to a G protein-phospholipase C-phosphatidylinositol4,5-bis- 
phosphate pathway can elicit a robust chloride current in 
denuded (follicle cell-less)  oocytes  (32,  33). Similarly,  potas- 
sium  currents,  although  much  smaller  in  magnitude,  are de- 
tected  in follicle cell-associated  oocytes upon ligand binding 
to G protein-coupled receptors  that  stimulate  adenylate cy- 
clase. In an effort to identify potential second messenger 
systems  through which the  yeast  pheromone receptor is  ca- 
pable of acting, we looked for any  changes  in  the  electrophys- 
iological properties of both  denuded  and folliculated  oocytes 
in which the STE2 protein was  expressed. In voltage clamp 
experiments,  no reproducible changes  in  membrane  conduct- 
ance were observed in  either  the  absence  or  presence of a- 
factor  (at  concentrations from 1 to 100 nM) over the voltage 
range between -100 and +80 mV (data  not  shown). 
Although it appeared that agonist binding to the yeast 
receptor failed to stimulate either the phosphatidylinositol 
4,5-bisphosphate- or adenylate cyclase-dependent signaling 
pathways,  the  absence of detectable electrophysiological  re- 
sponses could simply have been due  to  the inability of the 
yeast receptor to be recognized by amphibian G proteins 
resident in the oocyte. In an attempt to circumvent this 
potential problem, both  the  yeast  a-factor receptor and  its 
cognate G, subunit (GPAI gene product) were expressed 
simultaneously by  coinjection of both STE2 and GPAl 
mRNAs.  Such  an  approach  assumes, of course, that  the  yeast 
G, subunit, which shares  about 45%  sequence identity  with 
mammalian G,,, Gi,, and G, is  capable of coupling to verte- 
brate GB and G, subunits  and  capable of modulating  either 
vertebrate  phospholipase C or  vertebrate  adenylate cyclase. 
Oocytes injected with both the STE2 and GPAl mRNAs 
expressed a level of a-factor  binding  activity  equivalent  to 
that  seen  in oocytes  injected with STE2 mRNA alone  (data 
not shown). Moreover, these oocytes also synthesized the 
GPAl gene product as detected by immunoblotting of oocyte 
extracts  with affinity-purified GPAl -specific antibodies  (data 
not  shown).  The  apparent  mass of this species (-43 kDa) was 
slightly less than  that observed for the  product of in uitro 
translation of the  synthetic GPAl mRNA (-49 kDa)*  due to 
the high concentration of interfering proteins in this size 
range  in  the oocyte extracts.  Thus,  the  yeast G, subunit is 
expressed in oocytes injected with GPAl mRNA, but it is 
either  incapable of coupling with  vertebrate second  messenger 
systems  or  it  is  acting  upon a  second  messenger pathway  that 
does not  modulate  the  activity of any well characterized ion 
channel. Alternatively, if the  yeast G, subunit  cannot form a 
complex with frog GO and G, subunits,  the  resultant free yeast 
G, subunit may  be incapable of interacting  with  its  cognate 
receptor (STE2 protein). 
Certain  quantitative  considerations  argue  that, if the  yeast 
pheromone  receptor itself functions as any sort of ionic chan- 
nel, its average probability of opening  must be exceedingly 
low compared  with well characterized  ion  channels in animal 
(34, 35) and  yeast cells  (36). At a standard holding potential 
of  -60 mV (which we employed in some of our electrophysi- 
ological experiments),  the lower limit of current  detection (10 
nA) corresponds to a whole cell conductance of 1.7 x lo5 
picosiemens.  Given that high levels of expression of the a- 
factor  receptor were  achieved (6 x lo9 binding sites/oocyte), 
if the STE2 protein  functions  as  an ionic channel with  a unit 
conductance as small as 1 picosiemens, its  mean  open proba- 
bility must be less than 2.8 X in order to account for our 
inability to  detect  any  significant  current changes. Thus,  it 
seems extremely unlikely that  the STEZ protein possesses 
intrinsic ion channel  activity  or  is  an  a-factor-gated  channel 
for  any common ion; therefore,  the STEZ protein itself does 
















20850 Yeast  Pheromone  Receptor in Frog Oocytes 
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